Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic

NACompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

April 21, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

September 30, 2022

Conditions
Oncology
Interventions
OTHER

SCH Intervention

In addition to receiving usual care from their oncologist and staff, the SCH intervention group will report COVID-19 and cancer-related symptom presence and severity daily into the automated SCH system. Participants in the intervention receive automated self-management support messages for symptoms reported. In addition, COVID-19 symptoms and poorly controlled or worsening cancer symptoms will generate alerts. Based on preset thresholds, alerts automatically generate immediately from the patient's daily call data. The study nurse practitioners (NPs) monitor alerts. The NPs provide follow-up care using the guideline based SCH symptom clinical decision support system. The NPs log into the SCH Alert and Call Data website which displays all of the patients who have called that day and met an alert threshold. The NP calls the patient, delivers symptom management care by phone, and documents care in the patients' electronic health records.

Trial Locations (1)

84132

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04464486 - Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic | Biotech Hunter | Biotech Hunter